In Korea, where most of the thyroid malignancy is papillary carcinoma and BRAF mutation is highly prevalent, considerable number of BRAF-negative indeterminate thyroid nodules would be FVPTC. This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.